The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Q2
Biochemistry, Genetics and Molecular Biology (miscellaneous)
(2024)
Q3
Cancer Research
(2024)
Q2
Medicine (miscellaneous)
(2024)
Q3
Pharmacology
(2024)
5.
Élthes, Z. B.,
Sándor, K.,
Galuska, L.,
Farkas, B.,
Pető, S.,
Palatka, K.:
The role of FDG PET/CT in the and identification of fibrosis related to Crohn's disease.
J. Crohns Colitis. 19 (Suppl.), i524, 2025.
Kallos-Balogh, P.,
Vas, N. F.,
Tóth, Z.,
Szakáll, S.,
Szabó, P.,
Garai, I.,
Képes, Z.,
Forgács, A.,
Egeresi, L.,
Dahlbom, M.,
Balkay, L.:
Multicentric study on the reproducibility and robustness of PET-based radiomics features with a realistic activity painting phantom.
PLoS One. 19 (10), 1-24, (article identifier: 0309540), 2024.
Csikos, C.,
Czina, P.,
Molnár, S.,
Kovács, A. R.,
Garai, I.,
Krasznai, Z. T.:
Predicting Complete Cytoreduction with Preoperative [18F]FDG PET/CT in Patients with Ovarian Cancer: a Systematic Review and Meta-Analysis.
Diagnostics. 14 (16), 1-14, (article identifier: 1740), 2024.
Csikos, C.,
Barna, S.,
Kovács, Á.,
Budai, Á.,
Szolikova, M.,
Nagy, I. G.,
Husztik, B.,
Kiszler, G.,
Garai, I.:
Validation of an AI-Based Noise Reduction Filter on Bone Scan Images.
Eur. J. Nucl. Med. Mol. Imaging. 51 (Suppl.), S787, 2024.
Martinelli, J.,
Zapelli, L. M.,
Boccalon, M.,
Vágner, A.,
Nagy, G.,
Fekete, A.,
Szikra, D. P.,
Trencsényi, G.,
Baranyai, Z.,
Tei, L.:
AAZTA-like ligands bearing phenolate arms as efficient chelators for 68Ga labelling in vitro and in vivo.
Chem.-Eur. J. 29 (21), 1-11, (article identifier: 202203798), 2023.
Váradi, B.,
Brezovcsik, K.,
Garda, Z.,
Madarasi, E.,
Szedlacsek, H.,
Badea, R. A.,
Vasilescu, A. M.,
Puiu, A. G.,
Ionescu, A. E.,
Sima, L. E.,
Munteanu, C. V. A.,
Cǎlǎraş, S.,
Vágner, A.,
Szikra, D. P.,
Ngo, M. T.,
Nagy, T.,
Szűcs, Z.,
Szedlacsek, S. E.,
Nagy, G.,
Tircsó, G.:
Synthesis and characterization of a novel [52Mn]Mn-labelled affibody based radiotracer for HER2+ targeting.
Inorg. Chem. Front. 10 (16), 4734-4745, 2023.